Efficacy of the echOpen Device to Identify Effusion and to Detect Basilic Vein
CLIN-ECHO-I
Assessment of the echOpen Ultra-portable Ultrasound Device in Daily Use by Clinicians. Part I: Identification of Effusion and Detection of Basilic Vein
2 other identifiers
interventional
201
1 country
4
Brief Summary
In recent years, portable and ultra-portable ultrasound devices are increasingly used by the non radiologists, notably cardiologists or obstetrician gynecologist, at the patient's bedside to visualize and measure anatomical structures and fluid and provide the clinical examination with additional signs allowing quicker and more confident clinical decisions. This innovative approach is slowed down by the accessibility of these miniaturized devices, the price of which remains high. The echOpen device includes an ultra-portable ultrasound probe and a mobile application that allows the image to be displayed on a smartphone via a WIFI protocol. The objective of the clinical investigation is to show that the echOpen device, using three frequencies 3.5 Mhz, 5.0 Mhz and 7.5 Mhz, allows identifying the semiological signs or anatomical structures of interest located at several depths of the body, with a performance similar to other devices routinely used in clinical departments.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2022
Shorter than P25 for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 4, 2022
CompletedFirst Posted
Study publicly available on registry
March 15, 2022
CompletedStudy Start
First participant enrolled
April 4, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 19, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
August 19, 2022
CompletedDecember 8, 2022
December 1, 2022
5 months
March 4, 2022
December 7, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Presence of Pleural effusion
Presence or absence of pleural effusion as assessed by the echOpen device or by a portable ultrasound routinely used in the department
Day 0
Presence of Intra-abdominal effusion
Presence or absence of intra-abdominal effusion as assessed by the echOpen device or by a portable ultrasound routinely used in the department
Day 0
Basilic vein identification
Successful identification of the basilic vein using the echOpen device or a portable ultrasound routinely used in the department
Day 0
Secondary Outcomes (3)
Plural effusion detected using a gold standard procedure
Day 0
Intra-abdominal effusion detected using a gold standard procedure
Day 0
Basilic vein identification using a gold standard procedure
Day 0
Study Arms (1)
Patients benefitting ultrasound examination
EXPERIMENTALThis is the only arm of the study. Patients with an indicative clinical picture that leads the clinician to resort to the use of an ultrasound to potentially support the diagnosis will be examined to verify the presence of pleural effusion or intra-abdominal effusion, or to identify basilic vein. The patients will be assessed first with the echOpen device and second witn an ultrasound routinely used in the department. In a case of discordance between the assessments made with echOpen and the usual ultrasound device, an independent referent radiologist will use a standard ultrasound machine to constitute the gold standard (GS) rating
Interventions
Depending on the clinical picture, patients are examined to detect the presence or absence of pleural effusion, or intra-abdominal effusion, or to localize the basilic vein
Patients who were first examined with the EchOpen ultra-portable ultrasound device, are secondarily examined with an ultrasound probe used routinely in the department.
In a case of discordance between the assessments made with echOpen and the usual ultrasound device, an independent referent radiologist will use a standard ultrasound machine to constitute the gold standard (GS) rating
Eligibility Criteria
You may qualify if:
- Adult patient (age ≥ 18 years old)
- Patient having signed the informed consent to participate in this clinical investigation
- Patient affiliated to the social security scheme
- Patient arriving in the hospital clinical ward (own initiative or by emergency services) whose clinical symptomatology (e.g. dyspnea, thoracic pain, etc.) suggests the presence of pathological elements (effusion) which would be visible using an ultrasound probe
- Patient consulting in the hospital clinical ward who could potentially benefit from a basilic vein line placement using an ultrasound device
You may not qualify if:
- Minor patient (age \< 18 years)
- Patients under the "State medical assistance"
- Obese patient (body mass index \> 29.9)
- Patient in too serious condition for the clinical examination to be done fully and/or with additional exploratory time
- Unstable patient: need for immediate care, impossibility to carry out a thorough clinical examination including interview, palpation, auscultation, percussion
- Known allergy to ultrasound gel
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Assistance Publique - Hôpitaux de Parislead
- ECHOPENcollaborator
- EIT Healthcollaborator
Study Sites (4)
Avicenne Hospital - APHP - Hepatology Department
Bobigny, 93140, France
Cochin Hospital - APHP - Emergency Department
Paris, 75014, France
Cochin Hospital - APHP - Pneumology department
Paris, 75014, France
Paul Brousse Hospital - APHP - Hepatobiliary Center
Villejuif, 94800, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jérôme BOKOBZA, MD
AP-HP, Cochin Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Masking Details
- Open Label
- Purpose
- SCREENING
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 4, 2022
First Posted
March 15, 2022
Study Start
April 4, 2022
Primary Completion
August 19, 2022
Study Completion
August 19, 2022
Last Updated
December 8, 2022
Record last verified: 2022-12